Category:
Antibiotics and Antiviral Preparations
CAS NO:
179324-69-7
Standard:
N;
/
Bortezomib is a proteasome inhibitor synthesized via advanced peptide coupling and crystallization processes. It functions as a high-purity active pharmaceutical ingredient (API) designed for precise molecular targeting in oncology manufacturing.